Does the media favor ADUS or TOI?

In the previous week, Oncology Institute had 1 more articles in the media than Addus HomeCare. MarketBeat recorded 3 mentions for Oncology Institute and 2 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.79 beat Oncology Institute's score of 0.75 indicating that Addus HomeCare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Addus HomeCare 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Oncology Institute 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor AGL or TOI?

In the previous week, Oncology Institute had 2 more articles in the media than Agilon Health. MarketBeat recorded 3 mentions for Oncology Institute and 1 mentions for Agilon Health. Oncology Institute's average media sentiment score of 0.75 beat Agilon Health's score of 0.00 indicating that Oncology Institute is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilon Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Oncology Institute 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer SNDA or TOI?

In the previous week, Oncology Institute had 1 more articles in the media than Sonida Senior Living. MarketBeat recorded 3 mentions for Oncology Institute and 2 mentions for Sonida Senior Living. Sonida Senior Living's average media sentiment score of 0.81 beat Oncology Institute's score of 0.75 indicating that Sonida Senior Living is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sonida Senior Living 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Oncology Institute 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer TOI or VRDN?

In the previous week, Viridian Therapeutics had 2 more articles in the media than Oncology Institute. MarketBeat recorded 5 mentions for Viridian Therapeutics and 3 mentions for Oncology Institute. Oncology Institute's average media sentiment score of 0.75 beat Viridian Therapeutics' score of 0.31 indicating that Oncology Institute is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Oncology Institute 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Viridian Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Oncology Institute (TOI) Competitors

$5.18 -0.13 (-2.35%)

As of 09:45 AM Eastern

Compare

TOI vs. SGRY, ADUS, AGL, SNDA, and VRDN

Should you buy Oncology Institute stock or one of its competitors? MarketBeat compares Oncology Institute with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Oncology Institute include Surgery Partners (SGRY), Addus HomeCare (ADUS), Agilon Health (AGL), Sonida Senior Living (SNDA), and Viridian Therapeutics (VRDN). These companies are all part of the "healthcare" industry.

How does Oncology Institute compare to Surgery Partners?

Oncology Institute (NASDAQ:TOI) and Surgery Partners (NASDAQ:SGRY) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability, media sentiment and analyst recommendations.

In the previous week, Oncology Institute had 2 more articles in the media than Surgery Partners. MarketBeat recorded 3 mentions for Oncology Institute and 1 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 1.87 beat Oncology Institute's score of 0.75 indicating that Surgery Partners is being referred to more favorably in the news media.

Company	Overall Sentiment
Oncology Institute	Positive
Surgery Partners	Very Positive

36.9% of Oncology Institute shares are owned by institutional investors. 8.5% of Oncology Institute shares are owned by insiders. Comparatively, 2.0% of Surgery Partners shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Oncology Institute has higher earnings, but lower revenue than Surgery Partners. Surgery Partners is trading at a lower price-to-earnings ratio than Oncology Institute, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oncology Institute	$545.76M	0.94	-$60.61M	-$0.37	N/A
Surgery Partners	$3.31B	0.61	-$77.90M	-$0.60	N/A

Oncology Institute presently has a consensus target price of $7.25, indicating a potential upside of 39.83%. Surgery Partners has a consensus target price of $22.18, indicating a potential upside of 44.54%. Given Surgery Partners' stronger consensus rating and higher possible upside, analysts plainly believe Surgery Partners is more favorable than Oncology Institute.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oncology Institute	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Surgery Partners	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75

Oncology Institute has a beta of 0.37, indicating that its share price is 63% less volatile than the broader market. Comparatively, Surgery Partners has a beta of 1.96, indicating that its share price is 96% more volatile than the broader market.

Surgery Partners has a net margin of -2.28% compared to Oncology Institute's net margin of -7.42%. Surgery Partners' return on equity of 1.04% beat Oncology Institute's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Oncology Institute	-7.42%	N/A	-24.68%
Surgery Partners	-2.28%	1.04%	0.41%

Summary

Surgery Partners beats Oncology Institute on 10 of the 17 factors compared between the two stocks.

How does Oncology Institute compare to Addus HomeCare?

Addus HomeCare (NASDAQ:ADUS) and Oncology Institute (NASDAQ:TOI) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, earnings, risk, analyst recommendations and media sentiment.

Addus HomeCare has higher revenue and earnings than Oncology Institute. Oncology Institute is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Addus HomeCare	$1.42B	1.21	$95.91M	$5.41	17.11
Oncology Institute	$545.76M	0.94	-$60.61M	-$0.37	N/A

Addus HomeCare currently has a consensus price target of $131.00, indicating a potential upside of 41.52%. Oncology Institute has a consensus price target of $7.25, indicating a potential upside of 39.83%. Given Addus HomeCare's stronger consensus rating and higher probable upside, analysts plainly believe Addus HomeCare is more favorable than Oncology Institute.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Addus HomeCare	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.70
Oncology Institute	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Addus HomeCare has a net margin of 6.89% compared to Oncology Institute's net margin of -7.42%. Addus HomeCare's return on equity of 9.80% beat Oncology Institute's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Addus HomeCare	6.89%	9.80%	7.34%
Oncology Institute	-7.42%	N/A	-24.68%

In the previous week, Oncology Institute had 1 more articles in the media than Addus HomeCare. MarketBeat recorded 3 mentions for Oncology Institute and 2 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.79 beat Oncology Institute's score of 0.75 indicating that Addus HomeCare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Addus HomeCare	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Oncology Institute	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

95.4% of Addus HomeCare shares are held by institutional investors. Comparatively, 36.9% of Oncology Institute shares are held by institutional investors. 4.1% of Addus HomeCare shares are held by company insiders. Comparatively, 8.5% of Oncology Institute shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Addus HomeCare has a beta of 0.89, suggesting that its stock price is 11% less volatile than the broader market. Comparatively, Oncology Institute has a beta of 0.37, suggesting that its stock price is 63% less volatile than the broader market.

Summary

Addus HomeCare beats Oncology Institute on 15 of the 17 factors compared between the two stocks.

How does Oncology Institute compare to Agilon Health?

Agilon Health (NYSE:AGL) and Oncology Institute (NASDAQ:TOI) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, valuation, media sentiment, profitability, risk, dividends, earnings and institutional ownership.

36.9% of Oncology Institute shares are owned by institutional investors. 2.3% of Agilon Health shares are owned by company insiders. Comparatively, 8.5% of Oncology Institute shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Oncology Institute has lower revenue, but higher earnings than Agilon Health. Oncology Institute is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilon Health	$5.93B	0.30	-$391.35M	-$21.56	N/A
Oncology Institute	$545.76M	0.94	-$60.61M	-$0.37	N/A

Agilon Health presently has a consensus price target of $58.73, indicating a potential downside of 45.67%. Oncology Institute has a consensus price target of $7.25, indicating a potential upside of 39.83%. Given Oncology Institute's stronger consensus rating and higher probable upside, analysts plainly believe Oncology Institute is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilon Health	2 Sell rating(s)	8 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.20
Oncology Institute	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

In the previous week, Oncology Institute had 2 more articles in the media than Agilon Health. MarketBeat recorded 3 mentions for Oncology Institute and 1 mentions for Agilon Health. Oncology Institute's average media sentiment score of 0.75 beat Agilon Health's score of 0.00 indicating that Oncology Institute is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilon Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Oncology Institute	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Agilon Health has a beta of 3, suggesting that its stock price is 200% more volatile than the broader market. Comparatively, Oncology Institute has a beta of 0.37, suggesting that its stock price is 63% less volatile than the broader market.

Agilon Health has a net margin of -6.09% compared to Oncology Institute's net margin of -7.42%. Oncology Institute's return on equity of 0.00% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilon Health	-6.09%	-146.03%	-24.55%
Oncology Institute	-7.42%	N/A	-24.68%

Summary

Oncology Institute beats Agilon Health on 10 of the 16 factors compared between the two stocks.

How does Oncology Institute compare to Sonida Senior Living?

Sonida Senior Living (NYSE:SNDA) and Oncology Institute (NASDAQ:TOI) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and earnings.

In the previous week, Oncology Institute had 1 more articles in the media than Sonida Senior Living. MarketBeat recorded 3 mentions for Oncology Institute and 2 mentions for Sonida Senior Living. Sonida Senior Living's average media sentiment score of 0.81 beat Oncology Institute's score of 0.75 indicating that Sonida Senior Living is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sonida Senior Living	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Oncology Institute	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Oncology Institute has a net margin of -7.42% compared to Sonida Senior Living's net margin of -24.15%. Oncology Institute's return on equity of 0.00% beat Sonida Senior Living's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sonida Senior Living	-24.15%	-36.98%	-7.08%
Oncology Institute	-7.42%	N/A	-24.68%

87.6% of Sonida Senior Living shares are held by institutional investors. Comparatively, 36.9% of Oncology Institute shares are held by institutional investors. 39.3% of Sonida Senior Living shares are held by insiders. Comparatively, 8.5% of Oncology Institute shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Oncology Institute has higher revenue and earnings than Sonida Senior Living. Oncology Institute is trading at a lower price-to-earnings ratio than Sonida Senior Living, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sonida Senior Living	$411.85M	4.08	-$70.78M	-$5.83	N/A
Oncology Institute	$545.76M	0.94	-$60.61M	-$0.37	N/A

Sonida Senior Living has a beta of 0.78, meaning that its stock price is 22% less volatile than the broader market. Comparatively, Oncology Institute has a beta of 0.37, meaning that its stock price is 63% less volatile than the broader market.

Sonida Senior Living presently has a consensus price target of $40.50, suggesting a potential upside of 14.08%. Oncology Institute has a consensus price target of $7.25, suggesting a potential upside of 39.83%. Given Oncology Institute's stronger consensus rating and higher probable upside, analysts clearly believe Oncology Institute is more favorable than Sonida Senior Living.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sonida Senior Living	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Oncology Institute	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Summary

Oncology Institute beats Sonida Senior Living on 9 of the 16 factors compared between the two stocks.

How does Oncology Institute compare to Viridian Therapeutics?

Oncology Institute (NASDAQ:TOI) and Viridian Therapeutics (NASDAQ:VRDN) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, valuation, analyst recommendations, media sentiment, earnings, risk and institutional ownership.

Oncology Institute has a beta of 0.37, indicating that its share price is 63% less volatile than the broader market. Comparatively, Viridian Therapeutics has a beta of 0.9, indicating that its share price is 10% less volatile than the broader market.

36.9% of Oncology Institute shares are held by institutional investors. 8.5% of Oncology Institute shares are held by company insiders. Comparatively, 2.4% of Viridian Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Viridian Therapeutics had 2 more articles in the media than Oncology Institute. MarketBeat recorded 5 mentions for Viridian Therapeutics and 3 mentions for Oncology Institute. Oncology Institute's average media sentiment score of 0.75 beat Viridian Therapeutics' score of 0.31 indicating that Oncology Institute is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Oncology Institute	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Viridian Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Oncology Institute has a net margin of -7.42% compared to Viridian Therapeutics' net margin of -490.31%. Oncology Institute's return on equity of 0.00% beat Viridian Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Oncology Institute	-7.42%	N/A	-24.68%
Viridian Therapeutics	-490.31%	-80.19%	-48.84%

Oncology Institute presently has a consensus target price of $7.25, suggesting a potential upside of 39.83%. Viridian Therapeutics has a consensus target price of $36.14, suggesting a potential upside of 119.58%. Given Viridian Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Viridian Therapeutics is more favorable than Oncology Institute.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oncology Institute	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Viridian Therapeutics	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.79

Oncology Institute has higher revenue and earnings than Viridian Therapeutics. Oncology Institute is trading at a lower price-to-earnings ratio than Viridian Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oncology Institute	$545.76M	0.94	-$60.61M	-$0.37	N/A
Viridian Therapeutics	$70.85M	23.95	-$342.60M	-$3.32	N/A

Summary

Oncology Institute beats Viridian Therapeutics on 9 of the 16 factors compared between the two stocks.

Get Oncology Institute News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TOI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TOI vs. The Competition

Export

Metric	Oncology Institute	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$513.27M	$8.90B	$6.52B	$12.05B
Dividend Yield	N/A	1.71%	2.67%	5.66%
P/E Ratio	-14.03	24.23	24.00	24.42
Price / Sales	0.94	23.91	533.77	123.88
Price / Cash	N/A	13.73	27.48	37.92
Price / Book	-32.41	5.53	10.55	6.82
Net Income	-$60.61M	$177.22M	$3.57B	$337.56M
7 Day Performance	2.27%	1.54%	0.59%	1.16%
1 Month Performance	30.28%	10.04%	1.55%	3.16%
1 Year Performance	109.92%	5.88%	25.41%	30.60%

Oncology Institute Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TOI Oncology Institute	3.8171 of 5 stars	$5.19 -2.4%	$7.25 +39.8%	+115.0%	$513.27M	$545.76M	N/A	660
SGRY Surgery Partners	4.0569 of 5 stars	$13.96 +0.8%	$22.18 +58.9%	-32.7%	$1.83B	$3.31B	N/A	16,000	Positive News Gap Down
ADUS Addus HomeCare	3.8251 of 5 stars	$92.70 +2.2%	$131.22 +41.6%	-17.3%	$1.73B	$1.42B	17.13	50,659
AGL Agilon Health	1.2258 of 5 stars	$101.74 +6.7%	$58.73 -42.3%	+109.6%	$1.70B	$5.93B	N/A	1,076	Gap Up
SNDA Sonida Senior Living	2.6742 of 5 stars	$35.71 +6.6%	$40.50 +13.4%	N/A	$1.69B	$411.85M	N/A	5,140

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TOI) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Oncology Institute (TOI) Competitors

TOI vs. SGRY, ADUS, AGL, SNDA, and VRDN

How does Oncology Institute compare to Surgery Partners?

Summary

How does Oncology Institute compare to Addus HomeCare?

Summary

How does Oncology Institute compare to Agilon Health?

Summary

How does Oncology Institute compare to Sonida Senior Living?

Summary

How does Oncology Institute compare to Viridian Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TOI vs. The Competition

Oncology Institute Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Oncology Institute (TOI) Competitors

TOI vs. SGRY, ADUS, AGL, SNDA, and VRDN

How does Oncology Institute compare to Surgery Partners?

Does the media refer more to TOI or SGRY?

Do insiders and institutionals believe in TOI or SGRY?

Which has stronger earnings and valuation, TOI or SGRY?

Do analysts prefer TOI or SGRY?

Which has more risk and volatility, TOI or SGRY?

Is TOI or SGRY more profitable?

Summary

How does Oncology Institute compare to Addus HomeCare?

Which has stronger valuation & earnings, ADUS or TOI?

Do analysts recommend ADUS or TOI?

Is ADUS or TOI more profitable?

Does the media favor ADUS or TOI?

Do insiders & institutionals believe in ADUS or TOI?

Which has more risk and volatility, ADUS or TOI?

Summary

How does Oncology Institute compare to Agilon Health?

Do institutionals and insiders have more ownership in AGL or TOI?

Which has stronger valuation & earnings, AGL or TOI?

Do analysts prefer AGL or TOI?

Does the media favor AGL or TOI?

Which has more risk and volatility, AGL or TOI?

Is AGL or TOI more profitable?

Summary

How does Oncology Institute compare to Sonida Senior Living?

Does the media prefer SNDA or TOI?

Is SNDA or TOI more profitable?

Do insiders & institutionals hold more shares of SNDA or TOI?

Which has stronger earnings & valuation, SNDA or TOI?

Which has more risk & volatility, SNDA or TOI?

Do analysts prefer SNDA or TOI?

Summary

How does Oncology Institute compare to Viridian Therapeutics?

Which has more risk & volatility, TOI or VRDN?

Do institutionals and insiders have more ownership in TOI or VRDN?

Does the media prefer TOI or VRDN?

Is TOI or VRDN more profitable?

Do analysts recommend TOI or VRDN?

Which has better earnings and valuation, TOI or VRDN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TOI vs. The Competition

Oncology Institute Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools